Combination of Hypofractionated Proton Therapy With Immunotherapy
NCT03764787
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Proton Therapy
Immunotherapy
Interventions
COMBINATION_PRODUCT:
Radiation+PD-1 Ab
Sponsor
Peking University First Hospital
Collaborators
[object Object]